AstraZeneca Aktie
165,75
EUR
-1,05
EUR
-0,63
%
165,25
EUR
-1,70
EUR
-1,02
%
Erwachsen handeln.
Mit dem Broker, der Top-Insights, geprüfte Analysen
und Trading ab 0 € vereint (zzgl. Spreads).
Werbung
AstraZeneca Aktie Analyse
| 13.12.13 | AstraZeneca verkaufen | Jefferies & Company Inc. | |
| 27.08.13 | AstraZeneca verkaufen | Société Générale Group S.A. (SG) | |
| 20.08.13 | AstraZeneca verkaufen | Merrill Lynch & Co., Inc. | |
| 15.08.13 | AstraZeneca verkaufen | Morgan Stanley | |
| 11.06.13 | AstraZeneca verkaufen | Société Générale Group S.A. (SG) | |
| 26.04.13 | AstraZeneca verkaufen | Credit Suisse Group | |
| 25.04.13 | AstraZeneca verkaufen | S&P Equity Research | |
| 05.04.13 | AstraZeneca verkaufen | S&P Equity Research | |
|
Werbung
|
|||
| 20.03.13 | AstraZeneca verkaufen | Société Générale Group S.A. (SG) | |
| 27.02.13 | AstraZeneca verkaufen | J.P. Morgan | |
| 22.02.13 | AstraZeneca verkaufen | Credit Suisse Group | |
| 18.02.13 | AstraZeneca verkaufen | Nomura | |
| 12.02.13 | AstraZeneca verkaufen | J.P. Morgan | |
| 11.02.13 | AstraZeneca verkaufen | J.P. Morgan | |
| 01.02.13 | AstraZeneca verkaufen | S&P Equity Research | |
| 01.02.13 | AstraZeneca verkaufen | Independent Research GmbH | |
| 30.01.13 | AstraZeneca verkaufen | Nomura | |
| 21.01.13 | AstraZeneca Sell | Société Générale Group S.A. (SG) | |
| 12.12.12 | AstraZeneca underperform | Credit Suisse Group | |
| 30.10.12 | AstraZeneca verkaufen | Independent Research GmbH | |
| 29.10.12 | AstraZeneca underperform | Credit Suisse Group | |
| 16.10.12 | AstraZeneca underperform | Banc of America Securities-Merrill Lynch | |
| 05.10.12 | AstraZeneca verkaufen | Independent Research GmbH | |
| 04.10.12 | AstraZeneca reduce | Nomura | |
| 03.10.12 | AstraZeneca underperform | Credit Suisse Group | |
| 12.09.12 | AstraZeneca underperform | Banc of America Securities-Merrill Lynch | |
| 10.09.12 | AstraZeneca underperform | Banc of America Securities-Merrill Lynch | |
| 29.08.12 | AstraZeneca underperform | Exane-BNP Paribas SA | |
| 21.08.12 | AstraZeneca verkaufen | Independent Research GmbH | |
| 17.08.12 | AstraZeneca underperform | Credit Suisse Group | |
| 06.08.12 | AstraZeneca verkaufen | Independent Research GmbH | |
| 02.08.12 | AstraZeneca reduce | Nomura | |
| 27.07.12 | AstraZeneca underperform | Exane-BNP Paribas SA | |
| 18.07.12 | AstraZeneca underperform | Credit Suisse Group | |
| 18.07.12 | AstraZeneca underperform | Exane-BNP Paribas SA | |
| 18.07.12 | AstraZeneca reduce | Nomura | |
| 03.07.12 | AstraZeneca underperform | Credit Suisse Group | |
| 03.07.12 | AstraZeneca reduce | Nomura | |
| 02.07.12 | AstraZeneca underperform | Exane-BNP Paribas SA | |
| 21.06.12 | AstraZeneca underperform | Credit Suisse Group | |
| 15.06.12 | AstraZeneca underperform | Exane-BNP Paribas SA | |
| 05.06.12 | AstraZeneca underperform | Credit Suisse Group | |
| 04.05.12 | AstraZeneca verkaufen | Independent Research GmbH | |
| 27.04.12 | AstraZeneca underperform | Exane-BNP Paribas SA | |
| 23.04.12 | AstraZeneca reduce | Nomura | |
| 07.02.12 | AstraZeneca underperform | Banc of America Securities-Merrill Lynch | |
| 06.02.12 | AstraZeneca underperform | Exane-BNP Paribas SA | |
| 06.02.12 | AstraZeneca underperform | Credit Suisse Group | |
| 01.02.12 | AstraZeneca reduce | Nomura | |
| 21.12.11 | AstraZeneca reduce | Nomura | |
Werbung
Werbung